STRATEGIES FOR SELECTIVE CANCER PHOTOCHEMOTHERAPY: ANTIBODY‐TARGETED and SELECTIVE CARCINOMA CELL PHOTOLYSIS*

Photochemistry and Photobiology - Tập 46 Số 1 - Trang 83-96 - 1987
Allan R. Oseroff1,2, Gulshan Ara2, D. Ohuoha1,2, June R. Aprille3, Jerry C. Bommer4, Martin L. Yarmush5, J Foley6,7, Louis Cincotta6,7
1Department of Dermatology, New England Medical Center, Boston, MA 02111, USA.
2Wellman Laboratory, Department of Dermatology, Massachusetts General Hospital, Boston, MA 02114, USA
3Department of Biology, Tufts University, Medford, MA, USA
4Porphyrin Products, Inc., Logan, UT 84321, USA
5Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139 USA
62142, USA
7Rowland Institute for Science, Cambridge, MA

Tóm tắt

Abstract A principle objective in chemotherapy is the development of modalities capable of selectively destroying malignant cells while sparing normal tissues. One new approach to selective photochemo‐therapy, antibody‐targeted photolysis (ATPL) uses photosensitizers (PS) coupled to monoclonal antibodies (MAbs) which bind to eel) surface antigens on malignant cells. Selective destruction of human T leukemia cells (HBP‐ALL) was accomplished by coupling the efficient PS chlorin e6 to an anti‐T cell MAb using dextran carriers. Conjugates with chlorin : MAb ratios of 30 : 1 retained > 85% MAb binding activity, and had a quantum yield for singlet oxygen production of 0.7 ±0.1, the same as that of free chlorin e6. Cell killing was dependent on the doses of both MAb‐PS and 630‐670 nm light, and occurred only in target cell populations which bound the MAb. On the order of 1010 singlet oxygen molecules were necessary to kill a cell.A second approach to specific photochemotherapy, selective carcinoma cell photolysis (SCCP), relies on preferential accumulation of certain cationic PS by carcinoma cell mitochondria. We have evaluated several classes of cationic dyes, and in the case of N,N′‐bis‐(2‐ethyl‐1,3‐dioxolane)‐krypto‐cyanine (EDKC) and some of its analogs, have demonstrated highly selective killing of human squamous cell, bladder and colon carcinoma cells in vitro. In isolated mitochondria, EDKC uptake and fluorescence depended on membrane potential, and the dye specifically photosensitized damage to Complex I in the electron transport chain. N,N′‐bis‐(2‐ethyl‐1,3‐dioxolane)‐kryptocyanine and some of its analogs accumulated within subcutaneous xenografts of human tumors in nude mice with tumor : skin ratios > 8. Photoirradiation caused significant inhibition of tumor growth, without cutaneous phototoxicity.

Từ khóa


Tài liệu tham khảo

10.1111/1523-1747.ep12479191

10.1007/978-1-4684-4721-7

10.1111/j.1751-1097.1982.tb04338.x

10.1016/S0022-5347(17)51699-7

10.1038/bjc.1986.12

10.1126/science.6623064

10.1126/science.7146897

10.1016/0022-1759(83)90024-8

10.1001/archsurg.121.11.1272

Cantor C. R., 1980, Biophysical Chemistry. Part II: Techniques for the Study of Biological Structure and Function, 366

Davis S, 1985, Mitochrondrial and plasma membrane potentials cause unusual accumulation and retention of rhodamine 123 by human breast adenocarcinoma‐derived MCF‐7 cells, J. Bio. Chem., 260, 13844, 10.1016/S0021-9258(17)38802-6

10.1007/978-1-4684-4406-3_2

Dougherty T. J., 1978, A photoradiation therapy for the treatment of malignant tumors, Cancer Res., 38, 2628

Dougherty T. J., 1979, Photoradiation in the treatment of recurrent breast carcinoma, J. Natl. Cancer Inst., 62, 231

10.1111/j.1751-1097.1983.tb04472.x

10.1002/ijc.2910310520

Gibson S. L., 1983, Photosensitisation of mitochondrial cytochrome c oxidase by hematoporphyrin derivative and related porphyrins in vitro and in vivo, Cancer Res., 43, 4191

Goldberg E. P., 1983, Targeted Drugs

10.1111/j.1751-1097.1980.tb03772.x

Granick S., 1953, J. Biol. Chem., 202, 801, 10.1016/S0021-9258(18)66193-9

Hamer F. M.(1949)J. Chem. Soc.32–37.

10.1378/chest.81.3.269

Henderson B. W., 1984, Porphyrin Localization and Treatment of Tumors, 601

Henderson B. W., 1985, Tumor destruction and kinetics of tumor cell death in two experimental mouse tumors following photodynamic therapy, Cancer Res., 45, 572

Hilf R., 1986, Relationship of mitochondrial function and cellular adenosine triphosphate levels to hematoporphyrin derivative‐induced photosensitization in R3230AC mammary tumors, Cancer Res., 46, 211

10.1083/jcb.89.2.256

10.1083/jcb.88.3.526

10.1021/bi00634a023

Lampidis T. J., 1983, Selective toxicity of rhodamine‐123 in carcinoma cells in vitro, Cancer Res., 43, 716

10.1111/j.1751-1097.1981.tb05468.x

10.1016/S0021-9258(19)52451-6

Mew D., 1985, Ability of specific monoclonal antibodies and conventional antisera conjugated to hematoporphyrin to label and kill selected cell lines subsequent to light activation, Cancer Res., 45, 4380

Mew D., 1983, Photoimmunotherapy: treatment of animal tumors with tumor‐specific monoclonal antibody‐hem‐atoporphyrin conjugates, J. Immunol., 130, 1473, 10.4049/jimmunol.130.3.1473

Miller R. A., 1984, Monoclonal antibody trial in seven patients with T cell lymphoma, Blood, 62, 988, 10.1182/blood.V62.5.988.988

10.1016/0006-291X(84)91453-0

Musser D. A., 1984, Inability to elicit rapid cytocidal effects on L1210 cells derived from porphyrin‐injected mice following in vitro photoirradi‐ation, J. Natl. Cancer Inst., 73, 427

10.1073/pnas.83.22.8744

10.1073/pnas.83.24.9729

Oseroff A. R., 1985, Photosensitized destruction of normal and leukemic T cells using monoclonal antibody (MAb)‐directed hematoporphyrin, J. Invest. Dermatol., 84, 335

10.1016/S0092-8674(75)80001-8

10.1021/ja00358a001

Rowland G. F., 1983, Monoclonal antibodies for targeted therapy with vindesine, Prot. Biol. Fluids, 30, 315

Selman S. H., 1984, Blood flow in transplantable bladder tumors treated with hematoporphyrin derivative and light, Cancer Res., 44, 1924

10.1073/pnas.81.23.7584

10.1007/978-3-642-64961-5_6

Star W. M., 1986, Destruction of rat mammary tumor and normal tissue microcirculation by hematoporphyrin derivative photoradiation observed in vivo in Sandwich observation chambers, Cancer Res., 46, 2532

10.1073/pnas.79.17.5292

10.1111/j.1751-1097.1985.tb03450.x

10.1111/j.1600-065X.1982.tb00392.x

10.1111/j.1751-1097.1987.tb05384.x

10.1111/j.1600-065X.1982.tb00393.x